Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B

The bromodomain containing proteins BAZ2A/B play essential roles in chromatin remodeling and regulation of noncoding RNAs. We present the structure based discovery of a potent, selective, and cell active inhibitor 13 (BAZ2-ICR) of the BAZ2A/B bromodomains through rapid optimization of a weakly potent starting point. A key feature of the presented inhibitors is an intramolecular aromatic stacking interaction that efficiently occupies the shallow bromodomain pockets. 13 represents an excellent chemical probe for functional studies of the BAZ2 bromodomains in vitro and in vivo.

[1]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[2]  Babu Varghese,et al.  Intramolecular pi-stacking interaction in a rigid molecular hinge substituted with 1-(pyrenylethynyl) units. , 2007, The Journal of organic chemistry.

[3]  William A Weiss,et al.  Recognizing and exploiting differences between RNAi and small-molecule inhibitors. , 2007, Nature chemical biology.

[4]  G. Längst,et al.  NoRC—a novel member of mammalian ISWI‐containing chromatin remodeling machines , 2001, The EMBO journal.

[5]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[6]  M. Mackey,et al.  High content pharmacophores from molecular fields: a biologically relevant method for comparing and understanding ligands. , 2011, Current computer-aided drug design.

[7]  Jay Painter,et al.  Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .

[8]  Stefan Knapp,et al.  Bromodomains as therapeutic targets , 2011, Expert Reviews in Molecular Medicine.

[9]  S. Knapp,et al.  Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. , 2011, Molecular bioSystems.

[10]  I. Grummt,et al.  The structure of NoRC‐associated RNA is crucial for targeting the chromatin remodelling complex NoRC to the nucleolus , 2008, EMBO reports.

[11]  A. Gingras,et al.  Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family , 2012, Cell.

[12]  J. Wildeman,et al.  Chemistry of sulfonylmethyl isocyanides. 12. Base-induced cycloaddition of sulfonylmethyl isocyanides to carbon,nitrogen double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides , 1977 .

[13]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[14]  S. Knapp,et al.  Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains , 2014, Journal of the American Chemical Society.

[15]  I. Grummt,et al.  The PHD Finger/Bromodomain of NoRC Interacts with Acetylated Histone H4K16 and Is Sufficient for rDNA Silencing , 2005, Current Biology.

[16]  D. Huang,et al.  Evaluation of functional groups as acetyl-lysine mimetics for BET bromodomain inhibition , 2014 .

[17]  F. Diederich,et al.  Aromatic rings in chemical and biological recognition: energetics and structures. , 2011, Angewandte Chemie.

[18]  Nathan Brown,et al.  Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites , 2012, Journal of medicinal chemistry.

[19]  Chris Abell,et al.  Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain , 2013, Journal of medicinal chemistry.

[20]  S. Zukin,et al.  Epigenetics , 2009, Alzheimer's & Dementia.

[21]  R. Eils,et al.  BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence , 2014, Nature Genetics.

[22]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[23]  S. Knapp,et al.  Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening , 2013, Journal of medicinal chemistry.

[24]  S. Knapp,et al.  Targeting bromodomains: epigenetic readers of lysine acetylation , 2014, Nature Reviews Drug Discovery.

[25]  Owen Johnson,et al.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.

[26]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[27]  G. Wider,et al.  Measuring protein concentrations by NMR spectroscopy. , 2006, Journal of the American Chemical Society.

[28]  Nathan Brown,et al.  Fragment-based hit identification: thinking in 3D. , 2013, Drug discovery today.

[29]  A. Hofman,et al.  Identification of a Sudden Cardiac Death Susceptibility Locus at 2q24.2 through Genome-Wide Association in European Ancestry Individuals , 2011, PLoS genetics.

[30]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[31]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[32]  Stefan Knapp,et al.  The bromodomain interaction module , 2012, FEBS letters.

[33]  J. Nezu,et al.  A novel family of bromodomain genes. , 2000, Genomics.